NEVVI Medicare utilization intelligence
or

← back

Provider profile

PANDYA, DIPAKKUMAR M.D.

Neurology · NPI 1265486294 · ANNANDALE, NJ

2
Groups
19
Codes · 2024
40,599
Disclosed services

PANDYA, DIPAKKUMAR is a Neurology in ANNANDALE, NJ, a member of 2 medical groups, who billed 19 distinct codes to Medicare Part B in 2024.

Groups: HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (NEPTUNE, NJ) · HUNTERDON NEUROLOGY, PA (FLEMINGTON, NJ) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

40,599
disclosed services
19
codes billed to Medicare Part B
Prior year · CY2023 7,038 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0174 Injection, lecanemab-irmb, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2919 Injection, methylprednisolone sodium succinate, 5 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
95816 Measurement of brain wave activity (eeg), awake and drowsy
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96375 Injection of additional new drug or substance into vein
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
96413 Administration of chemotherapy into vein, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional
96132 Evaluation of neuropsychological test, first hour
96138 Administration of psychological or neuropsychological test by technician, first 30 minutes
96133 Evaluation of neuropsychological test, each additional hour

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.